Jennifer Larson
Chief Financial Officer · Bicara Therapeutics Inc.
Individual
- 2026
- Aug 14, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jennifer Larson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Claire Mazumdar - $3.59M in BCAX purchases and sales in the last 12 months
- Ryan Cohlhepp - $3.46M in BCAX purchases and sales in the last 12 months
- Ivan Hyep - $2.40M in BCAX purchases and sales in the last 12 months
- David Raben - $741K in BCAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jennifer Larson?
Jennifer Larson is a corporate insider, tracked as Chief Financial Officer of Bicara Therapeutics Inc. (BCAX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jennifer Larson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.